- Home
- RC vs FULC Comparison
RC vs FULC Comparison
Compare RC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RC
- FULC
- Stock Information
- Founded
- RC 2007
- FULC 2015
- Country
- RC United States
- FULC United States
- Employees
- RC N/A
- FULC N/A
- Industry
- RC Real Estate Investment Trusts
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- RC Real Estate
- FULC Health Care
- Exchange
- RC Nasdaq
- FULC Nasdaq
- Market Cap
- RC 517.6M
- FULC 468.1M
- IPO Year
- RC N/A
- FULC 2019
- Fundamental
- Price
- RC $2.39
- FULC $10.97
- Analyst Decision
- RC Hold
- FULC Buy
- Analyst Count
- RC 5
- FULC 7
- Target Price
- RC $5.75
- FULC $10.43
- AVG Volume (30 Days)
- RC 2.9M
- FULC 911.8K
- Earning Date
- RC 11-06-2025
- FULC 10-29-2025
- Dividend Yield
- RC 21.46%
- FULC N/A
- EPS Growth
- RC N/A
- FULC N/A
- EPS
- RC N/A
- FULC N/A
- Revenue
- RC N/A
- FULC N/A
- Revenue This Year
- RC N/A
- FULC N/A
- Revenue Next Year
- RC $141.93
- FULC N/A
- P/E Ratio
- RC N/A
- FULC N/A
- Revenue Growth
- RC N/A
- FULC 2752.05
- 52 Week Low
- RC $2.32
- FULC $2.32
- 52 Week High
- RC $7.64
- FULC $12.19
- Technical
- Relative Strength Index (RSI)
- RC 25.65
- FULC 65.44
- Support Level
- RC $2.62
- FULC $7.51
- Resistance Level
- RC $3.05
- FULC $12.19
- Average True Range (ATR)
- RC 0.16
- FULC 0.77
- MACD
- RC -0.02
- FULC 0.31
- Stochastic Oscillator
- RC 8.22
- FULC 74.39
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.